Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7091-7100 Newer>

The Motley Fool January 21, 2011 Brian Orelli	Trouble in Tysabri Land? Patient additions for a drug from Biogen Idec and Elan are slowing down.
The Motley Fool January 21, 2011 Brian Orelli	Mark Your Calendar, Drug Investors Vertex announces that the Food and Drug Administration has accepted its New Drug Application to market telaprevir.
BusinessWeek January 20, 2011 Anna Edney	The Doctors in the House Have an Agenda Republican physician-lawmakers want to dismantle a Medicare cost-cutting board that could hit doctors in their wallets.
The Motley Fool January 20, 2011 Brian Orelli	This Stock Is No Dreamboat The FDA is not kind to MannKind.
The Motley Fool January 20, 2011 Brian Orelli	Merck's Bleeding Out Vorapaxar caused it.
The Motley Fool January 20, 2011 Jim Royal	Big Pharma's Magic Formula Joel Greenblatt's Magic Formula revolves around two factors: How cheap is the stock? How profitable is the company? Let's see how some Big Pharma companies fare.
The Motley Fool January 20, 2011 Jeremy Phillips	Time to Sell Hospira? Hospira has failed two of the quick tests that would make it a sell. This is great, but does it mean you should hold your Hospira shares?
The Motley Fool January 19, 2011 Brian Orelli	A Painfully Protracted Partner Depomed is in a bind.
The Motley Fool January 19, 2011 Brian Orelli	High Stakes at Tomorrow's FDA Panel Meeting It's more than just Eli Lilly on the line.
The Motley Fool January 19, 2011 Cliff D'Arcy	Glaxo Stung by Legal Bill GSK shareholders are hit by costly legal settlements.
<Older 7091-7100 Newer> Return to current articles.